Tag: Luspatercept

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Luspatercept

Why James Levy Sold 12300000 Shares of Laredo Petroleum, Inc. (LPI)?; Acceleron Pharma Inc ...

Added to Collection on: 2018-11-18 02:00:00

Tags for this article:

Money
Finance
Economy
NASDAQ
Short
Laredo, Texas
Acceleron Pharma
Acceleron Pharma Inc.
Luspatercept
N-Shares
XLRN.O

Click the tags to see associated articles and topics

View Article Details
Imara closes $63M Series B funding round for blood disorder drug development

Added to Collection on: 2019-03-17 21:52:30

Tags for this article:

Medicine
Biology
RTT
Gene therapy
Branches of biology
Luspatercept
Sickle-cell disease
Red blood cell
Thalassemia
Hydroxycarbamide
Beta thalassemia
Sickle cell-beta thalassemia

Click the tags to see associated articles and topics

View Article Details
Acceleron Pharma (XLRN) Price Target Increased to $69.00 by Analysts at HC Wainwright

Added to Collection on: 2019-05-13 22:03:45

Tags for this article:

Financial markets
Financial economics
Finance
Equity securities
Stock market
Acceleron Pharma
Luspatercept
Stock
Share
Short
Acceleron Pharma Inc.
HC Wainwright

Click the tags to see associated articles and topics

View Article Details
Spark Investment Management LLC Takes $3.91 Million Position in Acceleron Pharma Inc (XLRN)

Added to Collection on: 2019-05-25 20:56:15

Tags for this article:

Financial markets
Finance
Financial economics
Equity securities
Stock market
Acceleron Pharma
Stock
Share
Luspatercept
Price?earnings ratio
Short
Spark Investment Management Llc
Acceleron Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
BlackRock Inc. Has $202.19 Million Stock Position in Acceleron Pharma Inc (NASDAQ:XLRN)

Added to Collection on: 2019-12-12 08:22:30

Tags for this article:

Financial markets
Financial economics
Finance
Acceleron Pharma
Short
Luspatercept
Stock
Acceleron Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
Agios' Tibsovo Wins FDA's Breakthrough Therapy Tag for MDS

Added to Collection on: 2019-12-16 23:33:45

Tags for this article:

Orphan drugs
Antineoplastic drugs
Health care
Health
Biotechnology
Agios Pharmaceuticals
Ivosidenib
Myelodysplastic syndrome
IDH1
Geron Corporation
Luspatercept
Food and Drug Administration

Click the tags to see associated articles and topics

View Article Details
Man Group plc Invests $452000 in Acceleron Pharma Inc (NASDAQ:XLRN)

Added to Collection on: 2020-01-01 16:15:00

Tags for this article:

Acceleron Pharma
Luspatercept
Price?earnings ratio
Health care
Health
Companies
Acceleron Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
Acceleron Pharma (NASDAQ:XLRN) Price Target Raised to $135.00 at Morgan Stanley

Added to Collection on: 2020-12-16 17:14:50

Tags for this article:

Financial markets
Acceleron Pharma
Financial economics
Luspatercept
Stock
Finance

Click the tags to see associated articles and topics

View Article Details
Global Thalassemia Treatment Market is estimated to be US$ 14.7 billion by 2030 with a CAGR of ...

Added to Collection on: 2021-04-30 14:09:29

Tags for this article:

Branches of biology
Genetic genealogy
Medical genetics
Hemoglobins
Thalassemia
Alpha-thalassemia
Beta thalassemia
Anemias
Hemoglobin subunit beta
Bluebird bio
Luspatercept
Gene therapy

Click the tags to see associated articles and topics

View Article Details
Best Practices and Strategies for Luspatercept in the Treatment of LR-MDS

Added to Collection on: 2025-01-31 16:35:15

Tags for this article:

Orphan drugs
Anemias
Luspatercept
Myelodysplastic syndrome
MDS

Click the tags to see associated articles and topics

View Article Details
Book a Demo